Effect and Adverse events of polyethylene glycol preparation combination in constipated patients with severe motor and intellectual disability

Effect and Adverse events of polyethylene glycol preparation combination in constipated patients with severe motor and intellectual disability - Effect and Adverse events of polyethylene glycol preparation combination in constipated patients with severe motor and intellectual disability

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000048883

Enrollment

Registered

2022-09-11

Start date

2021-01-14

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

severe motor and intellectual disability

Interventions

The drug was administered for 4 weeks,The method of administration was to administer the initial dose to 1 packet at a time, oral or enteral administration once a day for 7 days, and the dose was incr

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Patients over the age of 19 who are hospitalized in severe motor and intellectual disability ward 2)Patients diagnosed with constipation by doctor 3)Patients who are currently prescribed constipation medication but are prescribed cure medicines and use them frequency.

Exclusion criteria

Exclusion criteria: 1)rectal intussuspocion, rectal prolapse, and megacolon inducing constipation 2)mechanical obstruction 3)past history of inflammatory bowel diseases, colorectal cancer, or bowel obstruction 4)physician determined ineligible

Design outcomes

Primary

Measure	Time frame
the number of spontaneous defecation	—

Secondary

Measure	Time frame
the number of usage of cure medicines (e.g. glycerin enema),Stool hardness, adverse events	—

Countries

Japan

Contacts

Public ContactYASUFUMI TSURUSAKI

National Hospital Organization Higashisaga Hospital Department of pharmacy

tsurusaki.yasufumi.jm@mail.hosp.go.jp0942942048

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026